Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
179.80    2.40 (1.35%)
Bid:
179.70
Ask:
180.10
Spread: 0.40 (0.223%)
Market Cap: £794.45m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Trading Update

24 Sep 2020 07:00

RNS Number : 9370Z
Pets At Home Group Plc
24 September 2020
 

FOR IMMEDIATE RELEASE, 24 September 2020

Pets at Home Group Plc: Trading Update 

Sustained momentum across Retail and Veterinary operations

Pets at Home Group Plc, the UK's leading pet care business, today provides an update on trading in the first half of our financial year.

Our Q1 FY21 trading update on 31 July, covering the 16-week period from 27 March to 16 July 2020, highlighted that the last eight weeks of the Quarter had seen sales momentum returning across all areas of the business, reflecting normalisation of shopping habits amongst customers as well as the re-instatement of services and permitted procedures across our Retail and Veterinary operations.

This momentum has continued across both our Retail and Veterinary operations during Q2 FY21, delivering double-digit LFL growth in customer sales into and through the eight weeks to 10 September 2020.

This is testament to several factors, not least the inherent resilience in our pet care model and the underlying pet care market. We continue to benefit from the adaptability of our operations to changes in customer behaviour and preferences, our continuing investment in omnichannel capacity and customer acquisition channels, and the clear advantages of our unique owner-managed First Opinion veterinary model.

Although COVID-19 continues to create a number of material uncertainties around the trading environment, including the risk of a second lockdown, based on trading year to date, and as a consequence of the sustained strength in performance we have seen, we now expect full-year underlying pre-tax profit to be ahead of current market expectations1. Our balance sheet and liquidity remain strong.

We will announce our FY21 interim results on 24 November 2020.

 1. As at 23 September 2020, the Company compiled consensus for full year post-IFRS16 pre-tax profit was £73m

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulations (Regulation (EU) No.596/2014). For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by Roger Tejwani, Director of Investor Relations & External Communication.

 

Investor Relations Enquiries

Pets at Home Group Plc:

Roger Tejwani, Director of Investor Relations & External Communication+44 (0)1279 927022

Jonny Armstrong, Head of Investor Relations+44 (0)797 5593237

Media EnquiriesPets at Home Group Plc:

Gillian Hammond, Head of Media & Public Affairs+44 (0)7442 500138

Maitland/AMO

Clinton Manning+44 (0)7711 972662

Frederica Bendit+44 (0)7557 833442

 

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business; our commitment is to make sure pets and their owners get the very best advice, products and care. Pet products are available online or from our 451 stores, many of which also have vet practices and grooming salons. Pets at Home also operates a UK leading small animal veterinary business, with 441 First Opinion practices located both in our stores and in standalone locations, as well as four Specialist Referral centres. For more information visit: http://investors.petsathome.com/

 

Disclaimer

This trading statement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Pets at Home Group Plc shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser. Certain statements in this statement constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future plans and expectations, operations, financial performance, financial condition and business is a forwardlooking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKNBPFBKDDCB
Date   Source Headline
22nd Jan 20197:00 amRNSTrading Statement
17th Jan 20197:00 amRNSHolding(s) in Company
10th Jan 20195:16 pmRNSHolding(s) in Company
9th Jan 20195:17 pmRNSHolding(s) in Company
20th Dec 20187:00 amRNSExecutive Management Team Appointment
19th Dec 20185:20 pmRNSHolding(s) in Company
27th Nov 20187:00 amRNSInterim Financial Results
1st Nov 20187:00 amRNSExecutive Management Team Appointments
15th Oct 201811:21 amRNSChange in Director's details
12th Oct 201811:37 amRNSDirector/PDMR Shareholding
12th Oct 201811:37 amRNSDirector/PDMR Shareholding
12th Oct 201811:37 amRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSExecutive Management Team Changes
9th Oct 201812:54 pmRNSHolding(s) in Company
5th Oct 20182:37 pmRNSHolding(s) in Company
3rd Oct 20187:00 amRNSSegmental Reporting Information
1st Oct 201812:34 pmRNSDirector/PDMR Shareholding
14th Sep 20184:01 pmRNSDirector/PDMR Shareholding
3rd Aug 20187:00 amRNSQ1 Trading Statement
2nd Aug 20182:48 pmRNSHolding(s) in Company
19th Jul 201812:05 pmRNSDirector/PDMR Shareholding
12th Jul 20182:54 pmRNSResult of AGM
6th Jul 20187:09 amRNSHolding(s) in Company
6th Jul 20187:06 amRNSHolding(s) in Company
6th Jul 20187:00 amRNSHolding(s) in Company
5th Jul 201812:10 pmRNSHolding(s) in Company
4th Jul 20184:01 pmRNSHolding(s) in Company - Replacement
2nd Jul 20185:32 pmRNSHolding(s) in Company
2nd Jul 20185:31 pmRNSHolding(s) in Company
25th Jun 20182:37 pmRNSHolding(s) in Company
22nd Jun 20187:00 amRNSHolding(s) in Company
21st Jun 20184:09 pmRNSHolding(s) in Company
19th Jun 20182:02 pmRNSDirector/PDMR Shareholding
18th Jun 20186:11 pmRNSHolding(s) in Company
18th Jun 20186:11 pmRNSHolding(s) in Company
18th Jun 20182:15 pmRNSHolding(s) in Company
15th Jun 20185:33 pmRNSHolding(s) in Company
15th Jun 20182:04 pmRNSHolding(s) in Company
15th Jun 20187:07 amRNSHolding(s) in Company
15th Jun 20187:06 amRNSHolding(s) in Company
12th Jun 20183:14 pmRNSDirector/PDMR Shareholding
8th Jun 20184:29 pmRNSNotice of AGM
8th Jun 201812:30 pmRNSDirector/PDMR Shareholding
8th Jun 201812:28 pmRNSDirector/PDMR Shareholding
8th Jun 201812:27 pmRNSDirector/PDMR Shareholding
24th May 201811:27 amRNSDirector/PDMR Shareholding
24th May 201811:26 amRNSDirector/PDMR Shareholding
24th May 201811:25 amRNSDirector/PDMR Shareholding
24th May 201811:23 amRNSDirector/PDMR Shareholding
24th May 201811:17 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.